Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs
Clinical trial NCT03311789 · UNKNOWN
Trial details
- NCT number
- NCT03311789
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.